Friday, December 3, 2021
June 04 - 08, 2010; Chicago, Illinois
This coverage is not sanctioned by, nor a part of, the American Society of Clinical Oncology.
The materials presented here do not reflect the views of WebMD, LLC. These materials may discuss uses and dosages for therapeutic
products that have not been approved by the United States Food and Drug Administration. A qualified healthcare professional
should be consulted before using any therapeutic product discussed. All readers should verify all information and data before
treating patients or employing any therapies described in this article.
The materials presented here were prepared by independent authors under the editorial supervision of WebMD, LLC, and do not
represent a publication of the American Society of Clinical Oncology. These materials are not sanctioned by the American Society
of Clinical Oncology and do not constitute an official part of the conference.
Medscape Oncology© WebMD, LLC
Prostate Cancer: Immunotherapy Causes Paradigm Shift
Melanoma: Ipilimumab Improves Survival in Patients With Metastatic Melanoma
Blood Cancers: Individualizing Therapy and Integrating New Agents
GI Cancer: Making the Most of What We've Got
Breast Cancer: We Don't Need To Do What We Don't Need To Do
Lung Cancer: Tailoring Regimens to Patient Status and Tumor Vulnerability
From the Floor of the 2010 Annual Meeting of the American Society of Clinical Oncology
®
Gynecologic Cancers at ASCO
® 2010: Don't Miss
ASCO
® Plenary Session Features 2 NSCLC Studies
